CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ceftriaxone And Dextrose In Duplex Container, and what generic alternatives are available?
Ceftriaxone And Dextrose In Duplex Container is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER is ceftriaxone sodium. There are twenty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ceftriaxone And Dextrose In Duplex Container
A generic version of CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER was approved as ceftriaxone sodium by ANDA REPOSITORY on January 20th, 2017.
Summary for CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 45 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER at DailyMed |
Pharmacology for CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER
| Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER
US Patents and Regulatory Information for CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | ceftriaxone sodium | INJECTABLE;INJECTION | 050796-001 | Apr 20, 2005 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| B Braun | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | ceftriaxone sodium | INJECTABLE;INJECTION | 050796-002 | Apr 20, 2005 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
